USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: IMMUVEN, INC.
City: champaign
State: IL
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $448,552.00 2
SBIR Phase II $1,683,417.00 1

Award List:

Soluble high-affinity T cell receptors prevent MRSA lethality

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Adam Chervin – 217-979-1993
Award Amount: $151,529.00
Abstract:
DESCRIPTION (provided by applicant): Methicillin resistant Staphylococcus aureus (MRSA) and methicillin sensitive S. aureus (MSSA) are highly significant human health threats that are responsible for a range of diseases. Recently, the CDC and colleagues reported that MRSA are the most significant… More

Soluble high-affinity T cell receptors prevent MRSA lethality

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Adam Chervin – 217-979-1993
Award Amount: $1,683,417.00
Abstract:
DESCRIPTION (provided by applicant): Methicillin resistant Staphylococcus aureus (MRSA) and methicillin sensitive S. aureus (MSSA) are highly significant human health threats that are responsible for a range of diseases. Recently, the CDC and colleagues reported that MRSA are the most significant… More

Ultrasensitive Detection Probes for Staphylococcus aureus Enterotoxins

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Adam Chervin – 217-979-1993
Award Amount: $297,023.00
Abstract:
DESCRIPTION (provided by applicant): Staphylococcus aureus is a significant human health threat, producing exotoxins called superantigens, which are responsible for a range of diseases. S. aureus superantigens are associated with food-borne illnesses, pulmonary disease, pneumonia, toxic shock… More